Interna SK s.r.o.

At Interna SK s.r.o. in Svidnik, most trials focus on cardiovascular diseases, especially atherosclerotic cardiovascular disease, heart failure, hypertension, and related risk conditions. The research is aimed at testing new treatments, lowering the chance of major cardiac events, and improving long-term disease control.

• Studies in high-risk cardiovascular disease and ASCVD are evaluating ways to prevent heart attack, stroke, and other serious events.
• Several trials in heart failure are assessing treatments designed to reduce hospital visits and cardiovascular death.
• Research on hypertension is examining new options for people with difficult-to-control blood pressure.
• Additional work is exploring therapies for hyperlipidemia and elevated lipoprotein(a) to improve cardiovascular risk management.

This therapeutic area reflects a strong focus on prevention, symptom control, and better outcomes for patients with established or emerging heart and vessel disease.

The site also conducts research in nutritional and metabolic diseases, with studies linked to type 2 diabetes, obesity, overweight, and severe lipid disorders such as severe hypertriglyceridemia. These trials are mainly designed to assess whether new therapies can improve metabolic health and reduce related cardiovascular risk.

• Trials in type 2 diabetes and obesity are looking at treatments that may also lower the risk of heart-related complications.
• Research on severe hypertriglyceridemia is focused on improving abnormal blood fat levels and overall metabolic control.
• Some studies combine metabolic and cardiovascular goals, especially for patients with overweight or obesity plus existing heart disease.
• Work at Interna SK s.r.o. includes evaluating therapies that may support both weight management and broader cardiometabolic health.

Overall, this field emphasizes better treatment options for metabolic conditions that often contribute to long-term cardiovascular complications.